215 related articles for article (PubMed ID: 32800595)
21. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
22. Lymph node ratio as a prognostic factor in metastatic cutaneous head and neck squamous cell carcinoma.
Vasan K; Low TH; Gupta R; Ashford B; Asher R; Gao K; Ch'ng S; Palme CE; Clark JR
Head Neck; 2018 May; 40(5):993-999. PubMed ID: 29360276
[TBL] [Abstract][Full Text] [Related]
23. The role of parotidectomy for advanced cutaneous squamous cell carcinoma of the head and neck.
Kampel L; Dorman A; Horovitz G; Warshavsky A; Gutfeld O; Muhanna N
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3955-3963. PubMed ID: 33404750
[TBL] [Abstract][Full Text] [Related]
24. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of nodal metastatic cutaneous squamous cell carcinoma of the head and neck treated in a regional center.
Schmidt C; Martin JM; Khoo E; Plank A; Grigg R
Head Neck; 2015 Dec; 37(12):1808-15. PubMed ID: 24995842
[TBL] [Abstract][Full Text] [Related]
26. Patterns of lymph node metastasis of parotid cancer.
Shinomiya H; Otsuki N; Yamashita D; Nibu K
Auris Nasus Larynx; 2016 Aug; 43(4):446-50. PubMed ID: 26656731
[TBL] [Abstract][Full Text] [Related]
27. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck.
Khurana VG; Mentis DH; O'Brien CJ; Hurst TL; Stevens GN; Packham NA
Am J Surg; 1995 Nov; 170(5):446-50. PubMed ID: 7485729
[TBL] [Abstract][Full Text] [Related]
28. Better outcome for parotid versus neck metastasis of head and neck cutaneous squamous cell carcinoma: a new report on reemerging data.
Girardi FM; Wagner VP; Martins MD; Abentroth AL; Hauth LA
Braz J Otorhinolaryngol; 2021; 87(4):389-395. PubMed ID: 31870740
[TBL] [Abstract][Full Text] [Related]
29. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
[TBL] [Abstract][Full Text] [Related]
30. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
31. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
[TBL] [Abstract][Full Text] [Related]
32. Contralateral lymph node recurrence rate and its prognostic factors in stage IVA-B well-lateralized oral cavity cancer.
Chien JC; Hu YC; Chang KC; Huang YH; Huang CY; Kang BH; Liu WS
Auris Nasus Larynx; 2021 Oct; 48(5):991-998. PubMed ID: 33526320
[TBL] [Abstract][Full Text] [Related]
33. Results of a randomized controlled trial of level IIb preserving neck dissection in clinically node-negative squamous carcinoma of the oral cavity.
Pandey M; Karthikeyan S; Joshi D; Kumar M; Shukla M
World J Surg Oncol; 2018 Nov; 16(1):219. PubMed ID: 30409212
[TBL] [Abstract][Full Text] [Related]
34. Risk stratification of postoperative recurrence in hypopharyngeal squamous-cell carcinoma patients with nodal metastasis.
Lin H; Wang T; Heng Y; Zhu X; Zhou L; Zhang M; Shi Y; Cao P; Tao L
J Cancer Res Clin Oncol; 2021 Mar; 147(3):803-811. PubMed ID: 32728810
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.
Hinerman RW; Indelicato DJ; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Kirwan J; Mendenhall WM
Laryngoscope; 2008 Nov; 118(11):1989-96. PubMed ID: 18849863
[TBL] [Abstract][Full Text] [Related]
36. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers.
Forest VI; Clark JJ; Veness MJ; Milross C
Cancer; 2010 Mar; 116(5):1298-304. PubMed ID: 20052712
[TBL] [Abstract][Full Text] [Related]
37. Parotid gland metastasis in Merkel cell carcinoma of the head and neck: A series of 14 cases.
Day KE; Carroll WR; Rosenthal EL
Ear Nose Throat J; 2016 Sep; 95(9):398-404. PubMed ID: 27657318
[TBL] [Abstract][Full Text] [Related]
38. The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma.
Mooney CP; Clark JR; Shannon K; Palme CE; Ebrahimi A; Gao K; Ch'ng S; Elliott M; Gupta R; Low TH
Head Neck; 2021 Sep; 43(9):2705-2711. PubMed ID: 34019319
[TBL] [Abstract][Full Text] [Related]
39. Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
Oral Oncol; 2018 Nov; 86():188-194. PubMed ID: 30409299
[TBL] [Abstract][Full Text] [Related]
40. Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient.
Ebrahimi A; Clark JR; Lorincz BB; Milross CG; Veness MJ
Head Neck; 2012 Mar; 34(3):365-70. PubMed ID: 21472887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
